PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A mixture of essential oils including O. dictamnus (CAPeo) was found to reduce the duration and severity of symptoms in patients with upper respiratory tract infections [PMID:33298942] and showed potential in treating mild COVID-19 patients [PMID:37606476].
Dittany infusion demonstrated anti-inflammatory properties and low cytotoxicity in 3D-printed hydrogel patches for wound-healing [PMID:41740945].
Ursolic acid isolated from O. dictamnus exhibited cytotoxic activity against murine leukemia (P388) and human non-small cell lung cancer (NSCLC-N6) cell lines, with marginal antileukemic activity in vivo at 50 mg/kg [PMID:17507178].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 20633631 (2010) — Dittany of Crete: a botanical and ethnopharmacological review. · Journal of ethnopharmacology
- 2.PMID: 39444848 (2024) — Response of Origanum dictamnus L. (Cretan dittany) to Five Species of Root-Knot Nematodes (Meloidogyne spp.). · Journal of nematology
- 3.PMID: 26387739 (2015) — An ethnopharmacological and historical analysis of "Dictamnus", a European traditional herbal medicine. · Journal of ethnopharmacology
- 4.PMID: 36616309 (2023) — Cretan Dittany (Origanum dictamnus L.), a Valuable Local Endemic Plant: In Vitro Regeneration Potential of Different Type of Explants for Conservation and Sustainable Exploitation. · Plants (Basel, Switzerland)
- 5.PMID: 17507178 (2007)